この論文をさがす
説明
The apolipoprotein A-1 in cholestatic liver diseases was determined by rocket immunoelectrophoresis. A decrease in the serum apo A-1 was generally observed in LP-X positive liver disease, particularly in the patients with extrahepatic biliary obstruction. With reference to LP-X levels and LCAT activity, the results indicated that not only hepatocellular damage but also cholestasis contribute to the decrease of apo A-1 concentration in patients with liver disease.
収録刊行物
-
- Clinica Chimica Acta
-
Clinica Chimica Acta 87 85-92, 1978-07-01
Elsevier BV